Application of New Data in B-Cell Malignancies From ASCO and EHA 2020

ASCO 2020 Virtual Meeting/May 29-31, 2020
EHA 2020 Virtual Meeting/June 11-21, 2020
Lydia Scarfò, MD discusses key data in B-cell malignancies from EHA and ASCO 2020.
Lydia Scarfò, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 877 KB
Released: July 16, 2020

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

Downloadable slides with expert analysis of BCMA-targeted agents for RR multiple myeloma from Clinical Care Options.

Natalie S. Callander, MD Released: October 26, 2020

Natalie S. Callander, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 26, 2020 Expired: October 25, 2021

Download this short summary slideset of key topics in the evolving use of BCMA-targeted agents for RR multiple myeloma from Clinical Care Options.

Natalie S. Callander, MD Released: October 23, 2020

Clinical commentary by Dr. William Wierda on personalizing frontline treatment for chronic lymphocytic leukemia (CLL) from Clinical Care Options (CCO)

William G. Wierda, MD, PhD Released: October 22, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue